在癌症查试验中使用潜在的代用终点的考虑因素
Alexis B Webb1, Christine D Berg2, Philip E Castle3
1Cancer Research UK, London, UK.
The Lancet. Oncology
|May 2, 2024
概括
开发新的癌症查测试受到昂贵的长期试验的阻碍. 替代终点通过测量比癌症死亡率更早的结果提供解决方案,但验证仍然具有挑战性.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 生物统计学 生物统计学
背景情况:
- 大规模,长达十年的癌症查试验是昂贵的,并减缓了创新.
- 新型选试验在开发,商业化和实施方面面临重大障碍.
- 癌症死亡率是最终的终点,但它比查干预要晚得多.
研究的目的:
- 审查癌症查试验中选择和利用代用终点的挑战.
- 为癌症查中适当使用代用终点提出标准.
- 为了确定癌症查潜在的替代终点候选人.
主要方法:
- 对当前景观和替代终点使用挑战的文献综述.
- 分析从治疗试验环境中吸取的经验教训和缺陷.
- 对候选代用终点与定义的研究和监管标准进行讨论.
主要成果:
- 在验证代用终点方面存在重大挑战,即使有强大的研究设计.
- 目前在癌症查中使用代用终点的情况非常复杂.
- 来自治疗试验的经验教训强调了替代终点的潜力和陷.
结论:
- 替代终点是一种加速癌症查测试开发的潜在策略.
- 严格的验证至关重要,但对于癌症查中的代用终点很困难.
- 需要进一步的研究来确定和验证适合的替代终点,以获得监管机构的接受.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Assumptions of Survival Analysis
125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K


